Clinical Utility of HER2/ERBB2 Copy Number Analysis by Next Generation Sequencing in Metastatic Breast Cancer

被引：0
|
作者：
Xia, Daniel [1 ]
Kuo, Frank [2 ]
Dillon, Deborah [2 ]
机构：
[1] Univ Hlth Network, Toronto, ON, Canada
[2] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
来源：
LABORATORY INVESTIGATION | 2018年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
318
引用
收藏
页码：113 / 113
页数：1
相关论文
共 50 条
  • [31] Molecular mechanisms underlying ErbB2/HER2 action in breast cancer
    Daniel Harari
    Yosef Yarden
    [J]. Oncogene, 2000, 19 : 6102 - 6114
  • [32] Molecular mechanisms underlying ErbB2/HER2 action in breast cancer
    Harari, D
    Yarden, Y
    [J]. ONCOGENE, 2000, 19 (53) : 6102 - 6114
  • [33] Future options in the treatment of ErbB2 (HER2)-positive breast cancer
    Fumoleau, Pierre
    [J]. EJC SUPPLEMENTS, 2008, 6 (05): : 25 - 31
  • [34] Tucatinib HER2 (ErbB2) inhibitor Treatment of breast and colorectal cancer
    Patil, T.
    Shagisultanova, E.
    Borges, V. F.
    [J]. DRUGS OF THE FUTURE, 2019, 44 (01) : 11 - 19
  • [35] Munich Based Breast Cancer Symposium ErbB2(HER2)-positive metastatic Breast Cancer: The use of therapeutic Options
    Pohlmann, Birgit-Kristin
    [J]. BREAST CARE, 2012, 7 (01) : 74 - 77
  • [36] COMPLETE - Study the ErbB2 (HER2) - positive Breast cancer.
    Arnheim, Katharina
    Aktas, Bahriye
    [J]. ONKOLOGIE, 2010, 33 (04):
  • [37] ErbB2 (HER2)-positives MammakarzinomResistenzmechanismenErbB2 (HER2) positive breast cancer Mechanisms of resistance
    K. Kast
    W. Distler
    [J]. Der Gynäkologe, 2010, 43 (7): : 574 - 578
  • [38] Tucatinib Plus Trastuzumab and Capecitabine for ERBB2 (HER2)-Positive Metastatic Breast Cancer With Brain Metastases
    Mo, Dun-Chang
    Luo, Peng-Hui
    Huang, Jian-Feng
    [J]. JAMA ONCOLOGY, 2023, 9 (07) : 1008 - 1009
  • [39] Prognostic role of plasma HER2 gene copy number in patients with HER2 positive metastatic breast cancer.
    Ran, Ran
    Huang, Wenfa
    Lin, Shao
    Niu, Yunyun
    Rugo, Hope S.
    Kong, Weiyao
    Bo, Shiping
    Lu, Sijia
    Li, Huiping
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [40] RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer
    Singh, Harshabad
    Sahgal, Pranshu
    Kapner, Kevin
    Corsello, Steven M.
    Gupta, Hersh
    Gujrathi, Rahul
    Li, Yvonne Y.
    Cherniack, Andrew D.
    El Alam, Raquelle
    Kerfoot, Joseph
    Andrews, Elizabeth
    Lee, Annette
    Nambiar, Chetan
    Hannigan, Alison M.
    Remland, Joshua
    Brais, Lauren
    Leahy, Meghan E.
    Rubinson, Douglas A.
    Schlechter, Benjamin L.
    Meyerson, Matthew
    Kuang, Yanan
    Paweletz, Cloud P.
    Lee, Jessica K.
    Quintanilha, Julia C. F.
    Aguirre, Andrew J.
    Perez, Kimberly J.
    Huffman, Brandon M.
    Rossi, Humberto
    Abrams, Thomas A.
    Kabraji, Sheheryar
    Trusolino, Livio
    Bertotti, Andrea
    Sicinska, Ewa T.
    Parikh, Aparna R.
    Wolpin, Brian M.
    Schrock, Alexa B.
    Giannakis, Marios
    Ng, Kimmie
    Meyerhardt, Jeffrey A.
    Hornick, Jason L.
    Sethi, Nilay S.
    Cleary, James M.
    [J]. CLINICAL CANCER RESEARCH, 2024, 30 (08) : 1669 - 1684
12345